Fibromuscular Dysplasia (FMD) is a rare vascular disease that affects the arteries in various parts of the body, particularly in the renal and carotid regions. It is estimated that FMD occurs in about 4% of the population, mostly affecting women between ages 20-60. Despite its rarity, it's crucial for medical professionals to be knowledgeable about this condition as it can cause serious complications if left untreated. In this blog post, we will dive into what causes Fibromuscular Dysplasia and explore its symptoms and treatment options. So let's get started!
Fibromuscular Dysplasia (FMD) is a rare condition that affects the walls of arteries in your body, typically those leading to the kidneys or brain. The exact cause of FMD is unknown, but there are several theories.
One theory suggests that FMD may be caused by genetic factors. Research has found links between FMD and certain genes that regulate blood vessel development and function.
Another theory proposes that hormonal imbalances may lead to the development of FMD. Hormones such as estrogen have been linked to changes in arterial wall structure and function.
Some studies suggest that environmental factors such as smoking, high blood pressure, or infections may play a role in the development of FMD as well.
Fibromuscular Dysplasia (FMD) is a rare vascular disorder that affects the walls of arteries, causing them to thicken and narrow. The symptoms of FMD can vary depending on which arteries are affected and how severe the condition is.
One common symptom of FMD is high blood pressure, which may not respond well to medications. Other symptoms include headaches, dizziness, blurred vision or ringing in the ears. These symptoms are typically associated with narrowing or blockage of arteries in the brain.
In some cases, FMD can cause abdominal pain or discomfort due to narrowing or blockage of arteries leading to organs such as kidneys and intestines. This can also lead to digestive issues like nausea and vomiting.
Another symptom of FMD includes muscle weakness or numbness in an arm or leg due to reduced blood flow caused by artery damage. Some patients may also experience chest pains due to coronary artery involvement.
Fibromuscular Dysplasia is a rare but serious condition that affects the arteries in your body. It can lead to various complications such as high blood pressure, aneurysms or stroke if not treated properly.
It’s important for medical professionals to understand the causes and symptoms of Fibromuscular Dysplasia in order to provide accurate diagnosis and appropriate treatment options for their patients. Proper management of this condition involves a combination of lifestyle changes, medication, angioplasty or surgery depending on the severity of the case.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation